Cheapest GLP-1 Without Insurance (2026)
The lowest-cost ways to get a GLP-1 without insurance in 2026 — across both semaglutide and tirzepatide, with a side-by-side provider price comparison.
The cheapest GLP-1 without insurance in 2026 is the manufacturer's own self-pay program. The oral semaglutide pill is listed from ~$149/month via NovoCare; for injections, LillyDirect lists tirzepatide (Zepbound) vials from ~$299/month and NovoCare lists semaglutide pens at ~$349/month. All undercut the ~$1,000–$1,350 retail cash price. Broad cheap compounding ended when both shortages resolved. These are advertised estimates to confirm with the provider. This is information, not medical advice.
Last updated: June 2026 • 11 min read
GLP-1 Cost Comparison Without Insurance (2026)
Every cash-pay route to a GLP-1 in 2026, across both semaglutide and tirzepatide, ordered roughly cheapest to priciest. Prices are advertised rates checked in June 2026.
| Provider / Route | Drug | Form | Cash Price (estimate) | What to Know |
|---|---|---|---|---|
| NovoCare — oral Wegovy / Ozempic pill | Semaglutide (oral) | Pill | From ~$149/mo | Lowest published cash price for any FDA-approved GLP-1. $149/mo for 1.5 mg and 4 mg oral doses; the 4 mg price rises to $199/mo after Aug 31, 2026. Requires a prescription. |
| LillyDirect — Zepbound single-dose vials | Tirzepatide | Vial injection | ~$299–$449/mo | $299/mo for 2.5 mg, $399/mo for 5 mg, and $449/mo for 7.5–15 mg under the Zepbound Self Pay Journey Program (the $449 tier requires a refill within 45 days, or the price steps up). Lowest FDA-approved injectable GLP-1 for cash pay. |
| NovoCare — Wegovy / Ozempic pens | Semaglutide (injectable) | Pen injection | ~$349/mo | Standard self-pay price of ~$349/mo for most Wegovy and Ozempic pen doses; Wegovy HD 7.2 mg ~$399/mo and Ozempic 2 mg ~$499/mo. Periodic 2-fill intro offers have run lower. Requires a prescription. |
| Telehealth subscription (brand or, where allowed, compounded) | Semaglutide or tirzepatide | Varies | Visit/membership fee + drug | Telehealth platforms supply the prescription and delivery, then you pay either the manufacturer self-pay price or, in limited clinically justified cases, a compounded price. Many compounded GLP-1 programs are winding down after the shortages resolved. Compare the all-in monthly number, not the headline. |
| Compounded GLP-1 (limited / clinically justified only) | Semaglutide or tirzepatide | Vial injection | No longer broadly available | Once the cheapest route (~$99–$199/mo). Both shortages are resolved and routine mass compounding of a copy is no longer permitted; it may still be dispensed for documented clinical needs (e.g., an inactive-ingredient allergy). |
| Retail pharmacy cash counter (no program) | Any brand GLP-1 | Pen / vial | ~$1,000–$1,350/mo | The most expensive route. GoodRx lists Wegovy ~$1,349, Ozempic ~$1,219, and Mounjaro ~$1,347/mo for the common version; Lilly’s Mounjaro list (WAC) is ~$1,112/28-day supply. Discount cards help on some products, but manufacturer self-pay usually wins. |
Prices are advertised rates checked in June 2026 and change frequently. Confirm current pricing, dose eligibility, and program terms directly with the manufacturer or pharmacy before relying on a number. Compare cash-pay programs on the weight-loss provider directory.
Two GLP-1 Drug Families, Two Manufacturer Storefronts
"GLP-1" is a category, not one drug. For weight management in 2026 the two that matter are semaglutide (sold as Wegovy and Ozempic, made by Novo Nordisk) and tirzepatide (sold as Zepbound and Mounjaro, made by Eli Lilly). Tirzepatide is technically a dual GIP/GLP-1 agonist, but it is grouped with the GLP-1 class for shopping purposes. The cheapest-without-insurance answer is different for each family, which is why a semaglutide-only guide only tells half the story.
The single most useful 2026 development: both makers now sell their drug directly to cash payers, undercutting the retail pharmacy.
- Novo Nordisk → NovoCare for semaglutide. The oral pill is the budget entry point (~$149/mo); the injectable pens run a standard ~$349/mo.
- Eli Lilly → LillyDirect for tirzepatide. Zepbound single-dose vials are the cash-pay product, listed from ~$299/mo for the 2.5 mg starting dose.
If you have no insurance and no strong clinical preference yet, the practical move is to price the lowest dose of each family at its manufacturer storefront and compare the all-in number with a prescriber.
Cheapest Semaglutide: NovoCare Self-Pay
For semaglutide, the price floor is Novo Nordisk's own NovoCare program, which the company cut sharply under public and government pressure in late 2025.
- Oral pill from ~$149/month. The oral Wegovy and Ozempic pill formulations are listed from about $149/month for the 1.5 mg and 4 mg doses — the lowest published cash price for any FDA-approved GLP-1. Note the 4 mg price is scheduled to rise to $199/month after August 31, 2026.
- Injectable pens at a standard ~$349/month. Most Wegovy and Ozempic pen doses are ~$349/month self-pay; Wegovy HD 7.2 mg is ~$399/month and Ozempic 2 mg is ~$499/month. Periodic 2-fill introductory offers have run as low as ~$199/month for new starters.
- You still need a prescription. Self-pay does not skip the clinical step — a licensed prescriber must determine semaglutide is appropriate and write the script.
For the full deep-dive on just this family, see our cheapest way to get semaglutide guide.
Cheapest Tirzepatide: LillyDirect Zepbound Vials
For tirzepatide, the cash-pay floor is Eli Lilly's LillyDirect, which sells Zepbound as lower-priced single-dose vials (a self-injection drawn from a vial) rather than the pricier autoinjector pens. The vial program is the reason an FDA-approved tirzepatide can now start below a semaglutide pen.
- 2.5 mg starting dose: ~$299/month. The lowest FDA-approved injectable GLP-1 cash price.
- 5 mg: ~$399/month.
- 7.5 mg, 10 mg, 12.5 mg, 15 mg: ~$449/month under the Zepbound Self Pay Journey Program — but this tier requires refilling within 45 days of your previous delivery; miss that window and the price steps up to the higher regular self-pay rate for that fill.
- You still need a prescription, just as with semaglutide.
Watch the 45-day refill rule on higher doses. The ~$449/month price on 7.5 mg and up is contingent on staying on schedule. Budget for the possibility of a higher fill if life interrupts your refill timing, and confirm the current terms on LillyDirect.
Mounjaro (the same tirzepatide, branded for type 2 diabetes) is generally not the cheapest cash route for weight management — the Zepbound vial program is what brings the price down. For how the two tirzepatide brands compare to semaglutide, see our Mounjaro vs Ozempic comparison.
Where Telehealth Subscriptions Fit
Telehealth platforms are the convenience layer, not usually the price floor. They handle the prescription, sometimes coaching, and delivery — then you pay either the manufacturer self-pay price for the brand drug or, in the narrow cases where it is still allowed, a compounded price.
- Brand-drug telehealth: the platform gets you the prescription, then you pay the NovoCare or LillyDirect self-pay price above (some platforms integrate directly with those programs). Your added cost is the visit or membership fee.
- Membership math matters. A program that quotes a low drug price but adds a separate monthly membership can cost more all-in than a manufacturer storefront. Always add the fees together before comparing.
- Compounded telehealth is shrinking. Several platforms are winding down compounded GLP-1 offerings now that both shortages are resolved (see the next section).
The rule of thumb: a telehealth subscription is worth a premium if you value the coaching, the single bill, and the hand-holding. If you only want the lowest number, the manufacturer storefront usually wins. Compare cash-pay telehealth options on our telehealth services hub.
Compounded GLP-1s and Their Legal Status in 2026
Through 2023–2024 the cheapest GLP-1 was usually a compounded copy, advertised for roughly $99–$199/month, because drug shortages gave compounding pharmacies a legal lane. That lane has closed for both drugs.
- Tirzepatide: FDA declared the shortage resolved on December 19, 2024. Enforcement discretion for compounding ended February 18, 2025 for 503A state-licensed pharmacies and March 19, 2025 for 503B outsourcing facilities.
- Semaglutide: FDA declared the shortage resolved on February 21, 2025. Enforcement discretion ended April 22, 2025 for 503A pharmacies and May 22, 2025 for 503B facilities.
- Routine, mass compounding of a copy of either approved drug is no longer permitted. Compounded versions may still be dispensed in limited, clinically justified cases — for example, a documented allergy to an inactive ingredient that a prescriber notes on the prescription.
Legal challenges from compounder groups have not reversed the deadlines so far. If a website is still selling broad, no-questions compounded semaglutide or tirzepatide as a cheap copy, treat that as a reason to slow down rather than a deal. For the full picture of the rules and what they mean, see our compounded semaglutide guide and our roundup of Ozempic alternatives.
How Manufacturer Self-Pay Compares to the Retail Cash Counter
The reason the manufacturer programs matter is the gap to retail. Without any program, GoodRx lists Wegovy around $1,349/month, Ozempic around $1,219/month, and Mounjaro around $1,347/month for the most common version; Lilly's published list price (WAC) for Mounjaro is about $1,112 per 28-day supply as of January 1, 2026.
Against those numbers, NovoCare's ~$149–$349/month and LillyDirect's ~$299–$449/month are dramatic savings. Discount-card coupons can help on specific products and doses, but for the brand drugs the manufacturer's direct program is usually cheaper than walking up to the cash counter. The widely advertised "$25" savings cards generally apply only to commercially insured patients — not to the uninsured.
Shopping on Price Without Getting Scammed
Chasing the lowest GLP-1 price is exactly where people get hurt. Since late 2025 the FDA has issued many warning letters to sellers marketing GLP-1 medications improperly. Use these red flags as a checklist for either drug family:
- Claims of "FDA-approved compounded" semaglutide or tirzepatide — compounded drugs are not FDA-approved.
- No licensed prescriber involved, or a "questionnaire only" checkout with no real clinical review.
- The seller won't name the dispensing pharmacy or its state license.
- Overseas shipping of injectable medication, or vials sold as "research chemicals / not for human use."
- Prices that are far below even the manufacturer self-pay floor with no clinical explanation.
Note: Buy through a licensed US pharmacy or a telehealth service with real prescriber oversight. A slightly higher price from a legitimate source is cheaper than a bad outcome from an unsafe one.
How to Pick the Cheapest GLP-1 Route for You
Best for the lowest price
- ✓Oral semaglutide pill from ~$149/mo via NovoCare — the cheapest FDA-approved GLP-1 entry of any kind
- ✓LillyDirect Zepbound 2.5 mg vial at ~$299/mo — the cheapest FDA-approved injection
Best for support + convenience
- ✓Telehealth program for the prescription, delivery, and coaching bundled together
- ✓Compare the all-in number (visit/membership fee + drug), not the headline
A simple decision framework for an uninsured shopper:
- Decide with a prescriber which drug family fits you — semaglutide or tirzepatide.
- Price the lowest available dose at the matching manufacturer storefront (NovoCare or LillyDirect).
- If you want bundled support, price a telehealth program all-in and compare.
- Treat the bare retail cash price as the number to avoid, and check HSA/FSA eligibility to lower the effective cost.
Frequently Asked Questions
What is the cheapest GLP-1 without insurance in 2026?▼
Across both GLP-1 drug families, the lowest published cash price for an FDA-approved option is the oral Wegovy semaglutide pill at about $149 per month through NovoCare (the 4 mg dose rises to $199 after August 31, 2026). For an FDA-approved injection, Lilly’s LillyDirect lists Zepbound (tirzepatide) single-dose vials from about $299 per month for the 2.5 mg starting dose, and Novo Nordisk’s NovoCare lists Wegovy and Ozempic pens at a standard $349 per month. These are advertised prices that change often — confirm the current number with the manufacturer or pharmacy before relying on it.
What is the cheapest way to get a GLP-1 without insurance?▼
For most uninsured people the cheapest legitimate route is buying the FDA-approved drug directly from the manufacturer’s self-pay program rather than at a retail pharmacy. Novo Nordisk sells semaglutide through NovoCare (oral pill from ~$149/mo, pens at ~$349/mo standard) and Eli Lilly sells tirzepatide through LillyDirect (Zepbound vials from ~$299/mo). Both of these undercut the ~$1,000–$1,350 retail cash price. A telehealth visit can supply the prescription, but compare the all-in cost (visit fee plus drug), not just the headline. Prices are estimates to verify with the provider.
Which is the cheapest GLP-1 provider for cash pay?▼
There is no single cheapest provider for every dose. On the FDA-approved side, NovoCare (semaglutide) and LillyDirect (tirzepatide) are the manufacturer self-pay storefronts and are usually the price floor for the real brand drug — NovoCare’s oral pill from ~$149/mo is the lowest entry point, while LillyDirect Zepbound vials from ~$299/mo are the lowest FDA-approved injection. Telehealth platforms add a visit or membership fee on top. The right comparison is the same drug, the same dose, the same week, all-in. Confirm current pricing directly with each provider.
Is semaglutide or tirzepatide cheaper without insurance?▼
It depends on the form. The cheapest single option is the oral semaglutide pill (~$149/mo via NovoCare). For injections, tirzepatide via LillyDirect Zepbound vials (from ~$299/mo) can start lower than a semaglutide pen (~$349/mo via NovoCare), though semaglutide and tirzepatide are different medications with different dosing and tolerability, so the choice is clinical, not just price. At full retail both are roughly $1,000–$1,350 a month. Discuss which fits you with a licensed prescriber and verify the current price before starting.
Is compounded GLP-1 still the cheapest option online in 2026?▼
No longer broadly. The FDA declared both shortages resolved — tirzepatide on December 19, 2024 and semaglutide on February 21, 2025 — and the enforcement grace periods for mass compounding have ended (tirzepatide: February 18, 2025 for 503A pharmacies and March 19, 2025 for 503B facilities; semaglutide: April 22, 2025 and May 22, 2025). Routine large-scale compounding of a copy of either approved drug is no longer permitted; compounded versions may still be dispensed in limited, clinically justified cases. Treat an unusually cheap compounded GLP-1 online as a reason to slow down. This is information, not legal or medical advice.
How much does a GLP-1 cost at a pharmacy without insurance?▼
A lot more than the manufacturer self-pay programs. Without any program, GoodRx reports Wegovy around $1,349/month, Ozempic around $1,219/month, and Mounjaro around $1,347/month for the most common version; Lilly’s list (WAC) for Mounjaro is about $1,112 per 28-day supply as of January 1, 2026. Discount-card coupons cut some products, but the manufacturer’s direct self-pay price (NovoCare for semaglutide, LillyDirect for tirzepatide) is usually cheaper than the cash counter. Verify the current number at your specific pharmacy.
Compare GLP-1 Weight-Loss Programs
See cash-pay semaglutide and tirzepatide programs side by side — pricing, what is included, and how to get started.
View Weight-Loss Programs →Related Guides
Sources
- • NovoCare Pharmacy — Wegovy & Ozempic self-pay pricing
- • Novo Nordisk — Introductory $199/mo self-pay offer for Wegovy & Ozempic (press release)
- • LillyDirect — Zepbound (tirzepatide) self-pay pricing
- • Eli Lilly — Lilly lowers the price of Zepbound single-dose vials for self-pay patients (investor release)
- • Pharmaceutical Executive — Lilly reduces price of Zepbound single-dose vials for self-pay patients
- • GoodRx — How much is Mounjaro without insurance
- • GoodRx — Wegovy cost without insurance
- • FDA — Clarifies policies for compounders as national GLP-1 supply begins to stabilize
- • Pharmacy Times — FDA affirms tirzepatide shortage resolved, sets transition period for compounding
Medical disclaimer: This page is general information, not medical advice. Listings are aggregated from public sources and prices are estimates that may be out of date — confirm current pricing, services, and provider credentials directly with each clinic. Talk to a licensed clinician before starting any medication or treatment.
Affiliate disclosure: VitalityScout may earn a commission from some links, at no additional cost to you. This never affects which providers we list or how we describe them.
Comparing GLP-1 Prices?
Get our cash-pay GLP-1 price comparison across semaglutide and tirzepatide, plus what to ask before you commit to a program.
No spam, unsubscribe anytime.